osimertinib
astrazeneca
[]
 imo, flaws are regrettable, &amp; i don't like to feel manipulated by suboptimal execution that invariably helps sponsor company, but os curves are impressive. we're never going to get trial that overcomes these probs. adjuv osi is soc based on major dfs diff, &amp; os further supports.
Med Onc,@CityofHope; VP Netwk Strategy AccessHope, Founder,@CancerGRACE; Web Ed,@JAMAOnc; Author/Ed, @UptoDate

Telemed/digital med fan. 
Disclosures @ website